R2 (Rituximab & Lenalidomide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for R2 (Rituximab & Lenalidomide), covering 2019-10-09 to 2019-10-09. Get the full timeline:
Most recent: Clinical Trial Update: Intravitreal Methotrexate and R2(Rituximab & Lenalidomide) Regimen in Newly-diagnosed Primary Vitreoretinal Lymphoma [Phase 2]